CareDx (CDNA)
(Delayed Data from NSDQ)
$7.56 USD
-0.42 (-5.26%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $7.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CDNA 7.56 -0.42(-5.26%)
Will CDNA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CDNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDNA
CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last?
How CareDx (CDNA) Stock Stands Out in a Strong Industry
CDNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
CareDx (CDNA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Unlocking Q4 Potential of CareDx (CDNA): Exploring Wall Street Estimates for Key Metrics
How Much Upside is Left in CareDx (CDNA)? Wall Street Analysts Think 26.72%
Other News for CDNA
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
CareDx Appoints John W. Hanna as New CEO and Board Member
CareDx appoints John Hanna as president and CEO
CareDx names John Hanna as new CEO